Ahead of strategic update, new Sanofi CEO mulls options for consumer healthcare arm — reports
Big pharma has made moves to sharpen its focus on developing new medicines, while slow-growing consumer health divisions fall by the wayside. Looks like another large drugmaker is considering a similar move. On Thursday, reports citing sources indicated that Sanofi is reportedly mulling a joint venture, sale, or a public listing of its consumer health arm.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 83,200+ biopharma pros reading Endpoints daily — and it's free.